Studying the Association of Microrna‐210 Level with Chronic Hepatitis B Progression

G Song,H Jia,H Xu,W Liu,H Zhu,S Li,J Shi,Z Li,J He,Z Chen
DOI: https://doi.org/10.1111/jvh.12138
2013-01-01
Journal of Viral Hepatitis
Abstract:Summary We studied the relationship between hypoxia and micro RNA ‐210 (mi R ‐210) levels, the mi R ‐210 levels in patients with hepatitis B and the roles of mi R ‐210 in liver inflammation. We used the concanavalin A ( C on A ) murine hepatitis model and inflammation, hypoxia and mi R ‐210 levels were examined. In these patients, we studied serum mi R ‐210 levels and clinical indexes related to hepatitis in 90 patients with different stages of chronic hepatitis B and 30 controls. Two functional assays of mi R ‐210 in vitro under hypoxic condition were conducted. The animal experiments indicated that the liver and serum mi R ‐210 levels significantly increased with liver hypoxia and inflammation. In humans, serum mi R ‐210 levels enhanced with hepatitis severity and were related to serum alanine aminotransferase ( ALT ), aspartate aminotransferase ( AST ), total bilirubin ( TB ) and prothrombin activity ( PTA ) levels. The mi R ‐210 functional assays showed that mi R ‐210 elevation might be related to the decreases in HepG2.2.15 cell dehydrogenase activity and HBV replication under hypoxic conditions. Because the liver inflammation causes liver hypoxia which also results in liver and serum mi R ‐210 level elevation, the serum mi R ‐210 level may serve as a molecular biomarker for the severity of hepatitis and increases in liver mi R ‐210 that we see may be a response of hepatocytes to hypoxia during hepatitis progression.
What problem does this paper attempt to address?